| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.569 | 3.124 | 3.713 | 6.808 | 9.715 | 8.009 | 3.705 | 6.682 | 13.120 | 21.766 |
| Total Income - EUR | 1.653 | 3.126 | 3.713 | 6.809 | 9.722 | 8.009 | 3.705 | 6.682 | 13.120 | 22.458 |
| Total Expenses - EUR | 7.533 | 4.696 | 4.175 | 7.161 | 9.085 | 5.806 | 5.133 | 8.142 | 15.157 | 17.500 |
| Gross Profit/Loss - EUR | -5.880 | -1.570 | -463 | -352 | 637 | 2.203 | -1.428 | -1.460 | -2.037 | 4.957 |
| Net Profit/Loss - EUR | -5.929 | -1.663 | -574 | -549 | 345 | 1.986 | -1.539 | -1.558 | -2.168 | 4.294 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biomed Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.694 | 1.275 | 361 | 551 | 385 | 2.183 | 590 | 582 | 986 | 2.215 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 239 | 237 | 232 | 229 | 225 | 221 | 216 | 216 | 216 | 0 |
| Cash | 2.455 | 1.039 | 128 | 322 | 160 | 1.962 | 375 | 366 | 770 | 2.215 |
| Shareholders Funds | 1.533 | -147 | -718 | -1.255 | -885 | 1.118 | -446 | -2.005 | -4.167 | 150 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 1.162 | 1.422 | 1.079 | 1.806 | 1.270 | 1.065 | 1.036 | 2.587 | 5.153 | 2.065 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Biomed Plus Srl